Pharma

- Advertisement -
Ad imageAd image
Piramal Pharma and Ajinomoto Boost ADC Manufacturing

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a collaboration that is basically aimed at one thing. Making antibody-drug conjugate work move faster from early development to actual commercial…

LKJ, Isuzu and Fujitsu Begin Pharma Logistics Trial

Logistics Knight Japan Inc., Isuzu Motors Limited, and Fujitsu Limited will begin…

Chugai Pharmaceutical to Acquire Renalys Pharma

Chugai Pharmaceutical Co., Ltd. has made a firm deal to buy Renalys…

Ajinomoto Bio-Pharma and Gene Tools partner on PMO therapy

Ajinomoto Bio-Pharma Services has partnered with Gene Tools, LLC. This partnership aims…

Taiho Pharma Exercises Exclusive License for Casdatifan

Taiho Pharmaceutical Co., Ltd. and Arcus Biosciences, Inc. announced that Taiho exercised…

Alpha Fusion and Kobe Hospital launch At-211 Drug system

Alpha Fusion Inc. has announced a strategic collaboration with Kobe City Medical…

Rentschler Biopharma Expands in Japan and Korea

Rentschler Biopharma SE, a leading global CDMO for biopharmaceuticals, is boldly expanding…

Eisai and Biogen introduce LEQEMBI IQLIK for Alzheimer

Eisai Co., Ltd. and Biogen Inc. LEQEMBI® IQLIK™ (lecanemab-irmb) is now available…

LKJ, Isuzu and Fujitsu Begin Pharma Logistics Trial

Logistics Knight Japan Inc., Isuzu Motors Limited, and Fujitsu Limited will begin…

Chugai Pharmaceutical to Acquire Renalys Pharma

Chugai Pharmaceutical Co., Ltd. has made a firm deal to buy Renalys…

Ajinomoto Bio-Pharma and Gene Tools partner on PMO therapy

Ajinomoto Bio-Pharma Services has partnered with Gene Tools, LLC. This partnership aims…

Taiho Pharma Exercises Exclusive License for Casdatifan

Taiho Pharmaceutical Co., Ltd. and Arcus Biosciences, Inc. announced that Taiho exercised…

Alpha Fusion and Kobe Hospital launch At-211 Drug system

Alpha Fusion Inc. has announced a strategic collaboration with Kobe City Medical…

Rentschler Biopharma Expands in Japan and Korea

Rentschler Biopharma SE, a leading global CDMO for biopharmaceuticals, is boldly expanding…

Eisai and Biogen introduce LEQEMBI IQLIK for Alzheimer

Eisai Co., Ltd. and Biogen Inc. LEQEMBI® IQLIK™ (lecanemab-irmb) is now available…

- Advertisement -
Ad imageAd image

Join Our Community

Join Our Community